Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs

Fig. 3

a Biodistribution data and b tumor-to-background ratios of [177Lu]Lu-DOTA-rhCCK-91 (red) and [177Lu]Lu-DOTA-rhCCK-70 (blue) in selected organs (depicted in percentage injected dose per gram; %ID/g) at 24 h p.i. in comparison to [177Lu]Lu-DOTA-rhCCK-18 (grey, [20]) in AR42J tumor-bearing CB17-SCID mice (100 pmol each). Data of [177Lu]Lu-DOTA-rhCCK-18 taken from Günther et al. [20]. These data have been determined in our lab under identical conditions

Back to article page